Trilogy Metals (NYSEAMERICAN:TMQ - Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, April 2nd. Analysts expect the company to announce earnings of ($0.01) per share for the quarter.
Trilogy Metals Trading Down 3.6 %
NYSEAMERICAN:TMQ traded down $0.06 during trading hours on Friday, reaching $1.62. 415,296 shares of the stock were exchanged, compared to its average volume of 704,725. The stock has a market capitalization of $265.58 million, a PE ratio of -32.40 and a beta of 1.54. Trilogy Metals has a twelve month low of $0.25 and a twelve month high of $2.09. The company's 50 day simple moving average is $1.40.
About Trilogy Metals
(
Get Free Report)
Trilogy Metals Inc, a base metals exploration company, engages in the exploration and development of mineral properties in the United States. The company explores for copper, cobalt, lead, zinc, gold, and silver properties. It principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper - cobalt deposits covering an area of approximately 448,217 acres located in the Ambler mining district in Northwest Alaska.
See Also

Before you consider Trilogy Metals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trilogy Metals wasn't on the list.
While Trilogy Metals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.